Doctor Solves a Medical Mystery and Finds a Key to Alzheimer’s Disease

Doctor Solves a Medical Mystery and Finds a Key to Alzheimer’s Disease

For over a decade, big pharmaceutical companies have invested billions in Alzheimer's drug trials with little success. However, Dr. Paul Cox might have found a promising neuroprotective compound in our everyday diet. During his research on Guam's high rates of ALS and Alzheimer's-like symptoms in the 1990s, Cox discovered that cyanobacteria produced a toxin called BMAA. This toxin contaminated local food chains, leading to widespread neurodegenerative diseases among the island's population.


Dr. Cox's studies at the Brain Chemistry Labs revealed that L-serine, a non-essential amino acid found in various foods, could reduce BMAA's neurotoxic effects by 85% in monkeys. Encouraged by these results, Cox initiated clinical trials to explore L-serine as a potential Alzheimer's treatment. His confidence was bolstered by observations in Okinawa, where residents consume significantly more L-serine and enjoy greater longevity.

Despite not being a neurologist, Dr. Cox's ethnobotanical background and compelling evidence suggest that L-serine could become the first simple dietary-based treatment for Alzheimer's disease.




Good News Network

Image: Nu Skin Europe

Leave a comment

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.